By / November 22, 2021

Belgium startup launches production and sale of therapeutic cannabis CBD products

CBD (cannabidiol) is a molecule derived from cannabis. While many people already know about it, others have probably never heard of CBD. And yet, products based on CBD or other cannabis molecules can now be found just about everywhere, including in Belgium. These products are often sold in small quantities without the trader knowing exactly what they are. Worse, these products are also sold on numerous websites with a sometimes dubious origin.

Curious about the latest development in therapeutic cannabis and CBD in Belgium, eager to discover trends in the global cannabis market and hemp news? Download our companion hemp.IM app today!

A lack of information and increasing demand create gap in Belgium’s cannabis market

It was with this in mind that the start-up CBX Medical was created, located in the heart of Belgium’s Charleroi in the Trésignies barracks. There are three entrepreneurs from Belgium behind this young cannabis company: Jonathan Blondiau, Flora Mer and Lionel Quataert.

“All three of us have relatives who lacked information about CBD and who needed it. For example, one of them went to a CBD shop, in Belgium, because he suffers from osteoporosis and the salesman didn’t know what to say. That’s when we thought that these products should be available in pharmacies where you can get advice from a health professional,” explained Jonathan Blondiau.

“Two out of five doctors have already recommended the use of cannabidiol to their patients”

Because CBD and cannabis products are in high demand today, and not just in Belgium. 80 million Europeans use cannabinoids (a family of molecules that act on certain cells in the body and come from cannabis in particular) for curative or preventive purposes. “In Belgium, one in four people use them. There are also two doctors out of five who have already recommended their patients to use cannabidiol and yet there is no such product in pharmacies, so for us it was important that this changes since these products are used to treat oneself,” added Jonathan Blondiau.

Cannabis and CBD use grows in Belgium with effectiveness against several pathologies

CBX Medical now creates several types of products with the help of a scientific committee available to Belgium’s ould-be cannabis consumers. These include gels, oils, and patches. Several pharmacies in the Charleroi region have decided to sell the products created by CBX Medical.

One of these is the pharmacy of Hervé Mees in the Belgian town of Ressaix (Binche): “CBD-based products can be an alternative for certain patients who cannot be treated by conventional therapies. In some cases by using CBD, we see an improvement in their condition.

These products are used to combat stress and anxiety, chronic pain, to heat or cool muscles, and to treat the skin. While the cannabis originally used by CBX Medical comes from Eastern Europe and Switzerland, the CBD-rich products are manufactured in Belgium and undergo all the necessary tests before being marketed.

Fears nevertheless persist in Belgium about CBD and cannabis

Although CBD is becoming more and more known, many people are still unaware of the potential benefits of cannabinoid-based products. Some even fear them, as confirmed by pharmacist Hervé Mees: “Patients are very concerned because they make the link with cannabis, which remains a drug. So we have to reassure them that it’s not cannabis, there’s no dependence.” That’s where the pharmacist’s advice becomes very important.

These products are completely legal since they do not contain THC (editor’s note: the most psychoactive cannabinoid, the euphoric substance that makes you “high”). However, there is still a lack of clarity on the use of CBD oils, even if they are allowed to be sold. Hervé Mees hopes that this vacuum will be quickly resolved: “I think it’s time to be able to legislate correctly on the use of these CBD oils”.

Belgium needs to better train its pharmacists to keep up with the market

Not only do many people in Belgium have questions about CBD-based therapeutic products. Indeed, even some pharmacists remain ill-informed: “This is why we invest in training courses that are accredited, i.e. that pharmacists can follow. They serve to train them in the use of cannabinoids and thus to break down fears and barriers. They will then be able to advise their patients in the best possible way,” explains Jonathan Blondiau.

Today, sales of the products developed in Belgium by the start-up continue to increase. So we could well find more and more of these products in the region’s pharmacies in the months to come.

(Featured image by Roccm via Wikimedia Commons)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in rtbf, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Comments are closed for this post.